Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Psychostimulant pharmacological profile of paraxanthine, the main metabolite of caffeine in humans.

Orrú M, Guitart X, Karcz-Kubicha M, Solinas M, Justinova Z, Barodia SK, Zanoveli J, Cortes A, Lluis C, Casado V, Moeller FG, Ferré S.

Neuropharmacology. 2013 Apr;67:476-84. doi: 10.1016/j.neuropharm.2012.11.029. Epub 2012 Dec 19.

2.

Developmental lead exposure impairs extinction of conditioned fear in young adult rats.

McGlothan JL, Karcz-Kubicha M, Guilarte TR.

Neurotoxicology. 2008 Nov;29(6):1127-30. doi: 10.1016/j.neuro.2008.06.010. Epub 2008 Jul 10.

3.

Stimulation of adenosine receptors selectively activates gene expression in striatal enkephalinergic neurons.

Karcz-Kubicha M, Ferré S, Díaz-Ruiz O, Quiroz-Molina C, Goldberg SR, Hope BT, Morales M.

Neuropsychopharmacology. 2006 Oct;31(10):2173-9. Epub 2006 Feb 1.

4.

Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Ferré S, Goldberg SR.

Br J Pharmacol. 2005 Mar;144(5):642-50.

5.

Lack of adenosine A1 and dopamine D2 receptor-mediated modulation of the cardiovascular effects of the adenosine A2A receptor agonist CGS 21680.

Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Goldberg SR, Ferré S.

Eur J Pharmacol. 2004 Jan 26;484(2-3):269-75.

PMID:
14744613
6.

Enabling role of adenosine A1 receptors in adenosine A2A receptor-mediated striatal expression of c-fos.

Karcz-Kubicha M, Quarta D, Hope BT, Antoniou K, Müller CE, Morales M, Schindler CW, Goldberg SR, Ferré S.

Eur J Neurosci. 2003 Jul;18(2):296-302.

PMID:
12887411
7.

Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.

Karcz-Kubicha M, Antoniou K, Terasmaa A, Quarta D, Solinas M, Justinova Z, Pezzola A, Reggio R, Müller CE, Fuxe K, Goldberg SR, Popoli P, Ferré S.

Neuropsychopharmacology. 2003 Jul;28(7):1281-91. Epub 2003 Apr 9.

8.

Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function.

Ferré S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueño J, Gutiérrez MA, Casadó V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F.

Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11940-5. Epub 2002 Aug 20.

9.

Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens.

Solinas M, Ferré S, You ZB, Karcz-Kubicha M, Popoli P, Goldberg SR.

J Neurosci. 2002 Aug 1;22(15):6321-4.

10.

NMDA receptor antagonists acting at the glycineB site in rat models for antipsychotic-like activity.

Karcz-Kubicha M, Wedzony K, Zajaczkowski W, Danysz W.

J Neural Transm (Vienna). 1999;106(11-12):1189-204.

PMID:
10651113
11.
12.

Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats.

Karcz-Kubicha M, Quack G, Danysz W.

J Neural Transm (Vienna). 1998;105(10-12):1229-36.

PMID:
9928891
13.

GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality.

Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, Lazarewicz J, Quack G.

Amino Acids. 1998;14(1-3):235-9. Review.

PMID:
9871467
14.

Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.

Karcz-Kubicha M, Jessa M, Nazar M, Plaznik A, Hartmann S, Parsons CG, Danysz W.

Neuropharmacology. 1997 Oct;36(10):1355-67.

PMID:
9423923
15.
16.

Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test.

Karcz-Kubicha M, Liljequist S.

Eur J Pharmacol. 1995 Jun 12;279(2-3):171-7.

PMID:
7556398
17.

Zona incerta-lateral hypothalamus as an output structure for impulses involved in neuroleptic drug-induced catalepsy.

Ossowska K, Karcz-Kubicha M, Wardas J, Krezołek A, Wolfarth S.

Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):415-20.

PMID:
8099716
18.

Supplemental Content

Loading ...
Support Center